Certara's scientific consultants support strategic drug development decisions and submission-ready analyses.
Pharsight Consulting Services offers broad biostatistical expertise to support optimal trial design decisions, build the right dataset to achieve your target product profile, and perform critical analyses for your submission.
Protocol Study Designs, Statistical Analysis Plans
Data Summarization for Phase I-III
(Programming of Tables, Figures and Listings)
Inferential Statistics (Biostatistics) in Phase I-III Studies
CDISC, Dataset Construction and Regulatory Support
From Discovery through Development
Supporting Eleven Recent Drug Approvals with Model Based Drug Development
Certara’s Pharsight Consulting Services is applying quantative models to decision making, helping accelerate FDA approvals